Clinical Trial Update: BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a BUCYE conditioning regimen in primary CNS lymphoma patients undergoing autologous HSCT, spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• BUCYE conditioning regimen

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Primary Central Nervous System Lymphoma, Autologous Hematopoietic Stem Cell Transplantation | Phase 2, Phase 3 | Status: UNKNOWN